WH
WI Harper Group
Venture CapitalActiveWI Harper Group is a venture capital firm that focuses on early and expansion investments in Mainland China, Taiwan and Silicon Valley.
154
Investments
6
Exits
$1B
AUM
3.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for WI Harper Group.
Investment Thesis & Strategy
WI Harper Group invests in early and expansion-stage fintech, crypto/Web3, and venture capital companies in Mainland China, Taiwan, and Silicon Valley.
Investment Activity
Deals per year over the last 12 years
6
20070
20080
20092
20100
20110
20120
20130
20142
20150
20161
20171
2018Portfolio Companies
Selected investments from their portfolio of 154 companies
M
Medbanks
Healthcare · Series A, 2018
H
Harbour BioMed
Biotech · Series B, 2017
i
iCarbonX
Healthcare · Series A, 2015
I
Innovent Biologics
Biotech · Growth, 2015
V
Vcanbio
Biotech · Growth, 2010
Z
Zhejiang Weiming Environment Protection
Cleantech · Growth, 2010
C
China Biologic Products
Biotech · Growth, 2007
G
GenScript Biotech
Biotech · Growth, 2007
W
WuXi AppTec
Biotech · Growth, 2007
C
Celltrion
Biotech · Growth, 2007
3
3SBio
Biotech · Growth, 2007
B
BGI Group
Biotech · Growth, 2007
Notable Exits
CompanyTypeYearValue / Acquirer
GelesisIPO2022—
SinoMedIPO2018—
Innovent BiologicsIPO2018—
VobileIPO2014—
iDreamSkyIPO2014—
ChinaCacheIPO2010—
Frequently Asked Questions
WI Harper Group focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals